Heart‑Attack Alerts: How Blood Clues Predict Shock

Early Blood Markers May Flag Heart‑Attack Patients at Risk of Shock

A team of clinicians examined records from a single hospital where patients were admitted with ST‑segment elevation myocardial infarction (STEMI).
They investigated whether two routine blood tests—B‑type natriuretic peptide (BNP) and D‑dimer—could predict serious in‑hospital complications such as heart failure or cardiogenic shock.

Key Points

• BNP rises when the heart is under stress.
• D‑dimer indicates active blood clotting.
• The study combined these into a “BNP‑dominant biomarker phenotype” to create an early warning system.

Findings

Patients with elevated BNP and D‑dimer at admission were more likely to develop heart failure or shock during their stay.
This suggests that a rapid blood test could help clinicians identify high‑risk patients sooner and adjust treatment plans more aggressively.

Implications

If future research confirms these results, hospitals may adopt this dual‑marker approach as a standard part of emergency evaluation for heart‑attack patients, potentially improving survival and recovery times.